Home Privacy Archive Realtime Report

Stock Trading History of Carter Kenneth C

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Carter Kenneth C since year 2005. The trader's CIK number is 1332217. At the time of this reporting, Carter Kenneth C is the President and CEO of Avalon Pharmaceuticals Inc (stock ticker symbol AVRX).

Stock purchases, sales, and option exercises reported by *Carter Kenneth C* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2008-01-17	AVRX	Avalon Pharmaceuticals Inc	Sale	2,032	2.56	5,191
2008-01-23	AVRX	Avalon Pharmaceuticals Inc	Purchase	4,832	2.55	12,308
2006-08-30	AVRX	Avalon Pharmaceuticals Inc	Purchase	3,000	2.99	8,970
2006-08-22	AVRX	Avalon Pharmaceuticals Inc	Purchase	2,000	3.27	6,540

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Carter Kenneth C (President and CEO of Avalon Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.